PLI Schemes Achieve Significant Manufacturing and Export Milestones
The Production Linked Incentive (PLI) Schemes for 14 key sectors have achieved substantial results with ₹2.40 lakh crore in cumulative investments and over 14.15 lakh jobs generated (direct and indirect) as of March 31, 2026. The schemes, launched with an approved financial outlay of ₹1.91 lakh crore, are designed to enhance India's manufacturing capabilities, attract investments, increase exports, generate employment, and improve global competitiveness.
Sector-wise Investment and Employment Performance
According to Annexure-I data, the Large Scale Electronics Manufacturing sector led with ₹20,580 crore investment and 1,69,249 employment, followed by Pharmaceuticals Drugs with ₹45,158 crore investment and 1,14,880 jobs. High Efficiency Solar PV Modules attracted ₹64,873 crore investment while generating 14,794 jobs. Automobiles & Auto Components sector recorded ₹44,326 crore investment with 67,820 jobs, and Specialty Steel attracted ₹23,896 crore investment. The Food Products sector generated the highest employment at 3,29,200 jobs with ₹9,207 crore investment.
Remarkable Export Growth and Sectoral Achievements
Cumulative exports under PLI Schemes have shown exceptional growth, increasing from ₹4.0 lakh crore in FY 2023-24 to ₹6.5 lakh crore in FY 2024-25, and reaching ₹15.2 lakh crore in FY 2025-26. The Large Scale Electronics Manufacturing sector achieved particularly notable results with mobile phone production increasing by 2.4 times since scheme launch, mobile phone imports declining by 77%, and 99.2% of mobile phones used in India now manufactured domestically.
Pharmaceutical and Medical Device Manufacturing Strengthened
The Pharmaceuticals sector recorded cumulative sales of ₹3.64 lakh crore and enabled domestic manufacture of 1,931 pharmaceutical products, including 191 bulk drugs manufactured in India for the first time. The Bulk Drugs sector established manufacturing capacity of approximately 55,000 MT across 26 critical Active Pharmaceutical Ingredients, reducing import dependence for products like Paracetamol, Levofloxacin, and Norfloxacin. The Medical Devices scheme facilitated domestic manufacturing of advanced equipment including CT Scanners, MRI Systems, Cath Labs, and Ultrasonography equipment, with 22 applicants commencing operations and 55 unique medical devices commissioned.
Diverse Sectoral Impacts and Implementation Framework
The Telecom & Networking Products sector supported development of indigenous 4G technology and domestic manufacturing capability for 5G telecom equipment. The White Goods scheme contributed to significant expansion with compressor manufacturing capacity increasing from 1 million units in 2021 to 10 million units in 2025-26, alongside improved localization of key components like PCBAs and Cross Flow Fans. The Department for Promotion of Industry and Internal Trade (DPIIT) serves as the nodal department for coordination and monitoring, while respective Administrative Ministries/Departments implement their respective schemes. Implementation is reviewed periodically by the Empowered Group of Secretaries (EGoS) chaired by the Cabinet Secretary, with modifications carried out based on stakeholder feedback to address implementation challenges.